Concepedia

William Mietlowski

WM

22

Publications

2.3K

Citations

18

H-Index

1975

Active since

Affiliations

Novartis (United States)(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Frontier Science & Technology Research Foundation

United States Department of Veterans Affairs

William Mietlowski is an author at Novartis (United States) specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1975–2012

22

Publications

22

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Catherine Lhommé, Florence Joly, Joan L. Walker et al. · Journal of Clinical Oncology · 2008 · 154 citations · Full text

Cyclosporine as maintenance therapy in patients with severe psoriasis

Jerome L. Shupack, Elizabeth Abel, Eugene A. Bauer et al. · Journal of the American Academy of Dermatology · 1997 · 102 citations · Full text

A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis

Stanley H. Appel, Scott Stewart, Vicki Appel et al. · Archives of Neurology · 1988 · 96 citations

Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung

James D. Cox, Raymond Yesner, William Mietlowski et al. · Cancer · 1979 · 94 citations

Rows per page

1–5 of 22